Effects produced by Royal Jelly on haematopoiesis: Relation with host resistance against Ehrlich ascites tumour challenge

International Immunopharmacology

Volumn 5, Issue 4, 2005, Pages 679-688

  Bincoletto, Claudia ^a,b   Eberlin, Samara ^a   Figueiredo, Camila A V ^a   Luengo, Marcos B ^a   Queiroz, Mary L S ^a  

^a UNIVERSITY OF CAMPINAS   (Brazil)

^b UNIVERSIDADE DE MOGI DAS CRUZES   (Brazil)

Author keywords

Erhlich ascites tumour; GM CFU; Haematopoiesis; LTBMC; Royal Jelly

Indexed keywords

IMMUNOMODULATING AGENT; PROSTAGLANDIN E2; ROYAL JELLY;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTINEOPLASTIC ACTIVITY; ARTICLE; BONE MARROW CULTURE; BONE MARROW SUPPRESSION; CANCER IMMUNOTHERAPY; CANCER PREVENTION; CANCER SURVIVAL; CELL SURVIVAL; CONTROLLED STUDY; CORRELATION ANALYSIS; DRUG DOSE REGIMEN; DRUG EFFECT; DRUG EFFICACY; EHRLICH ASCITES TUMOR; EXPERIMENTAL MOUSE; HEMATOPOIESIS; HEMATOPOIETIC STEM CELL; HOST RESISTANCE; IMMUNOMODULATION; IMMUNOREACTIVITY; IMMUNOSTIMULATION; LOW DRUG DOSE; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROSTAGLANDIN BLOOD LEVEL; SPLEEN DISEASE; SURVIVAL RATE; SURVIVAL TIME; TUMOR GROWTH;

EID: 13844292595     PISSN: 15675769     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.intimp.2004.11.015     Document Type: Article

References (58)

1. E.S. Sunila, and G. Kuttan Immunomodulatory and antitumor activity of Piper longum Linn. and piperine J. Ethnopharmacol. 90 2004 339 346
2. K.I. Block, and M.N. Mead Immune system effects of echinacea, ginseng, and astragalus: a review Integr. Cancer Ther. 2 2003 247 267
3. Y. Miyazawa, T. Murayama, N. Ooya, L.F. Wang, Y.C. Tung, and N. Yamaguchi Immunomodulation by a unicellular green algae (Chlorella pyrenoidosa) in tumor-bearing mice J. Ethnopharmacol. 24 1988 135 146
4. M.C. Valadares, S.I. Klein, A.M. Guaraldo, and M.L.S. Queiroz Enhancement of natural killer cell function by titanocenes in mice bearing Ehrlich ascites tumour Eur. J. Pharmacol. 25 2003 191 196
5. L. Mirandola, G.Z. Justo, and M.L.S. Queiroz Modulation by Acanthospermum australe extracts of the tumor induced hematopoietic changes in mice Immunopharmacol. Immunotoxicol. 24 2002 275 288
6. G.Z. Justo, N. Dúran, and M.L.S. Queiroz Myelopoietic response in tumour-bearing mice by an aggregated polymer isolated from Aspergillus oryzae Eur. J. Pharmacol. 388 2000 219 226
7. D.C.M. Dantas, and M.L.S. Queiroz Effects of Chlorella vulgaris on bone marrow progenitor cells of mice infected with Listeria monocytogenes Int. J. Immunopharmacol. 21 1999 499 508
8. M.H. Haydak Larval food and development of castes in the honey bee J. Econ. Entomol. 36 1943 778 792
9. N. Weaver, and K.A. Kuiken Quantitative analysis of the essential amino acids of royal jelly and some pollens J. Econ. Entomol. 44 1951 635 638
10. N.G. Patel, M. Haydak, and T.A. Gochnauer Electrophoretic components of the proteins in honey bee larval food Nature 186 1960 633 634
11. A. Karaali, F. Meydanoglu, and D. Eke Studies on composition, freeze-drying and storage of turkish royal jelly J. Apic. Res. 27 1988 182 185
12. B.C. Bloodworth, C.S. Harn, C.T. Hock, and Y.O. Boon Liquid chromatographic determination of trans-10-hydroxy-2-decenoic acid content of commercial products containing royal jelly J. AOAC Int. 78 1995 1019 1023
13. L. Sver, N. Orsolic, Z. Tadic, B. Njari, and I. Valpotic A royal jelly as a new potential immunomodulator in rats and mice Comp. Immunol. Microbiol. Infect. Dis. 19 1996 31 38
14. Y. Taniguchi, K. Kohno, S. Inoue, S. Koya-Miyata, I. Okamoto, and N. Arai Oral administration of royal jelly inhibits the development of atopic dermatitis-like skin lesions in NC/Nga mice Int. Immunopharmacol. 3 2003 1313 1324
15. I. Okamoto, Y. Taniguchi, T. Kunikata, K. Kohno, K. Iwaki, and M. Ikeda Major royal jelly protein 3 modulates immune responses in vitro and in vivo Life Sci. 5 2003 2029 2045
16. Y. Emori, H. Oka, O. Ohya, H. Tamaki, H. Hayashi, and K. Nomoto The protective effect of royal jelly against the hemopoiesis dysfunction in X-irradiated mice Biotherapy 12 1998 313 319 [in Japanese]
17. H. Oka, Y. Emori, N. Kobayashi, Y. Hayashi, and K. Nomoto Suppression of allergic reactions by royal jelly in association with the restoration of macrophage function and the improvement of Th1/Th2 cell responses Int. Immunopharmacol. 1 2001 521 532
18. T.M. Walker, C.J. Burger, and K. Elgert Tumor growth alters T cell and macrophage production of and responsiveness to granulocyte-macrophage colony-stimulating factor: partial deregulation through interleukin-10 Cell. Immnunol. 154 1994 342 357
19. R.L. DeGowin, D.P. Gibson, S.A. Knapp, and L.M. Wathen Tumor-induced suppression of marrow stromal colonies Exp. Hematol. 9 1981 811 819
20. R.A. Lang, D. Metcalf, N.M. Gough, A.R. Dunn, and T.J. Gonda Expression of a hemopoietic growth factor cDNA in a factor-dependent cell line results in autonomous growth and tumorigenicity Cell 43 1984 531 542
21. W.E. Berdel, S. Danhauser-Riedl, G. Steinhauser, and E.F. Winton Various human hematopoietic growth factors (interleukin-3, GM-CSF, G-CSF) stimulate clonal growth of nonhematopoietic tumor cells Blood 73 1989 80 83
22. Y.X. Fu, G.A. Watson, M. Kasahara, and D.M. Lopez The role of tumor-derived cytokines on the immune system of mice bearing a mammary adenocarcinoma: I. Induction of regulatory macrophages in normal mice by the in vivo administration of rGM-CSF J. Immunol. 146 1991 783 789
23. P.J. Carry, D.M. Prescott, and G.I. Ogilvie Resistance to Ehrlich ascites tumor in a strain of dystrophic mice Cancer Res. 39 1979 2139 2140
24. M.L.S. Queiroz, G.Z. Justo, M.C. Valadares, F.R.R. Pereira-da-Silva, and A.H. Müller Adjuvant effect of Pluchea quitoc extract on the resistance of tumor-bearing mice by modulation of the host hematopoietic response Immunopharmacol. Immunotoxicol. 23 2001 215 228
25. J.L. Subiza, J.E. Vinuela, R. Rodriguez, J. Gil, M.A. Figueredo, and E.G. De La Concha Development of splenic natural suppressor (NS) cells in Ehrlich tumour-bearing mice Int. J. Cancer 4 1989 307 314
26. Z. Werb D.P. Stiter J.D. Stobo J.V. Wells Basic and Clinical Immunology 6th ed. 1987 Appleton & Lasnge Norwalk 96
27. H.W. Murray, and Z.A. Cohn Mononuclear phagocyte antimicrobial and antitumour activity: the role of oxygen intermediates J. Invest. Dermatol. 74 1980 285 288
28. C.F. Nathan, H.W. Murray, M.E. Wiebe, and B.Y. Rubin Identification of interferon-gamma as the lymphokine that activates human macrophage oxidative metabolism and antimicrobial activity J. Exp. Med. 158 1983 670 689
29. W.G. Spector, and G.B. Ryan Mononuclear phagocytes 1970 Blackwell Oxford 219
30. D. Fecchio, P. Sirois, and M. Russo Studies on inflamatory response induced by Ehrlich Tumor in mice peritoneal cavity Inflammation 14 1990 125 132
31. J.A.S. Nelson, R.S. Pahar, J.M. Scodras, and P.K. Lala Down-regulation of macrophage I-A expression in tumor-bearing mice J. Leukoc. Biol. 48 1990 394 402
32. I.L. Bonta, and S. Ben-Efraim Involvement of inflammatory mediators in macrophage antitumor activity J. Leukoc. Biol. 54 1993 613 626
33. H. Fujiwara, and T. Hamaoka Regulatory mechanisms of antitumor T cell responses in the tumor-bearing state Immunol. Res. 14 1995 271 291
34. K.D. Elgert, D.G. Alleva, and D.W. Mullins Tumor-induced immune dysfunction: the macrophage connection J. Leukoc. Biol. 64 1998 275 290
35. M. Baum, and B. Fisher Macrophage production by the bone marrow of tumor bearing mice Cancer Res. 32 1972 2813 2817
36. C.L. Hardy, and L. Balducci Review: haemopoietic alterations in cancer Am. J. Med. Sci. 290 1985 196 205
37. J. Levin, and F.B. Bang Clottable protein Limulus: its localization and kinetics of its coagulation by endotoxin Thromb. Diath. Haemorrh. 19 1968 186 197
38. D. Metcalf Clonal culture of hemopoietic cells: techniques and applications 1984 Elsevier Amsterdam 167
39. T.M. Dexter, T.D. Allen, and L.G. Lajtha Conditions controlling the proliferation of haemopoietic stem cells in vitro J. Cell. Physiol. 91 1977 335 344
40. A. Pessina, P. Brambilla, S. Villa, A. Marocchi, and P. Mocarelli Factors produced by macrophages and tumour cells: influence on the granulocytic precursor cells (CFU-C) in normal and tumour bearing mice J. Cancer Res. Clin. Oncol. 102 1982 235 244
41. R.J. Da Silva, M.G. Da Silva, L.C. Vilela, and D. Fecchio Cytokine profile of Ehrlich ascites tumor treated with Bothrops jararaca venom Mediat. Inflamm. 11 2002 197 201
42. R.M. Fauve, B. Hevin, H. Jacob, J.A. Gaillard, and F. Jacob Antiinflammatory effects of murine malignant cells Proc. Natl. Acad. Sci. U. S. A. 71 1974 4052 4056
43. R. Snyderman, and M.C. Pike An inhibitor of macrophage chemotaxis produced by neoplasms Science 23 1976 370 372
44. J.I. Kurland, P.W. Kincade, and M.A. Moore Regulation of B-lymphocyte clonal proliferation by stimulatory and inhibitory macrophage-derived factors J. Exp. Med. 146 1977 1420 1435
45. R.M. Schultz, N.A. Pavlidis, W.A. Stylos, and M.A. Chirigos Regulation of macrophage tumoricidal function: a role for prostaglandins of the E series Science 20 1978 320 321
46. J.S. Goodwin, and D.R. Webb Regulation of the immune response by prostaglandins Clin. Immunol. Immunopathol. 15 1980 106 122
47. L.M. Pelus, and R.S. Bockman Increased prostaglandin synthesis by macrophages from tumor-bearing mice J. Immunol. 123 1979 2118 2125
48. R.A. Morantz, G.W. Wood, M. Foster, M. Clark, and K. Gollahon Macrophages in experimental and human brain tumors: Part 2. Studies of the macrophage content of human brain tumors J. Neurosurg. 50 1979 305 311
49. S.W. Russell, G.Y. Gillespie, C.B. Hansen, and C.G. Cochrane Inflammatory cells in solid murine neoplasms: II. Cell types found throughout the course of Moloney sarcoma regression or progression Int. J. Cancer 15 1976 331 335
50. J.E. Talmadge, M. Key, and I.J. Fidler Macrophage content of metastatic and nonmetastatic rodent neoplasms J. Immunol. 126 1981 2245 2248
51. G.A. Watson, Y.X. Fu, and D.M. Lopez Splenic macrophages from tumor-bearing mice co-expressing MAC-1 and MAC-2 antigens exert immunoregulatory functions via two distinct mechanisms J. Leukoc. Biol. 49 1991 126 138
52. A.S. Koo, C. Armstrong, B. Bochner, T. Shimabukuro, C.L. Tso, and J.B. deKernion Interleukin-6 and renal cell cancer: production, regulation, and growth effects Cancer Immunol. Immunother. 35 1992 97 105
53. J.A. Segura, L.G. Barbero, and J. Márquez Early tumour effect on splenic Thymphocytes in mice FEBS Lett. 414 1997 1 6
54. F.F. Hamerlinck Neopterin: a review Exp. Dermatol. 9 1999 167 176
55. S. Aizawa, M. Hiramoto, S. Araki, S. Negishi, Y. Kimura, and H. Hoshi Stimulatory effects of neopterin on hematopoiesis in vitro are mediated by activation of stromal cells function Hematol. Oncol. 16 1998 57 67
56. C. Huber, J.R. Batchelor, D. Fuchs, A. Hausen, A. Lang, and D. Niederwieser Immune response-associated production of neopterin. Release from macrophages primarily under control of interferon-gamma J. Exp. Med. 160 1984 310 316
57. K. Kohno, I. Okamoto, O. Sano, N. Arai, K. Iwaki, and M. Ikeda Royal jelly inhibits the production of proinflammatory cytokines by activated macrophages Biosci. Biotechnol. Biochem. 68 2004 138 145
58. A. Fujii, S. Kobayashi, N. Kuboyama, Y. Furukawa, Y. Kaneko, and S. Ishihama Augmentation of wound haling by royal jelly (RJ) in streptozotocin-diabetic rats Jpn. J. Pharmacol. 53 1990 331 337